Correlation Between Statera Biopharma and Mymetics Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Statera Biopharma and Mymetics Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Statera Biopharma and Mymetics Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Statera Biopharma and Mymetics Corp, you can compare the effects of market volatilities on Statera Biopharma and Mymetics Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Statera Biopharma with a short position of Mymetics Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Statera Biopharma and Mymetics Corp.

Diversification Opportunities for Statera Biopharma and Mymetics Corp

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Statera and Mymetics is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Statera Biopharma and Mymetics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mymetics Corp and Statera Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Statera Biopharma are associated (or correlated) with Mymetics Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mymetics Corp has no effect on the direction of Statera Biopharma i.e., Statera Biopharma and Mymetics Corp go up and down completely randomly.

Pair Corralation between Statera Biopharma and Mymetics Corp

Given the investment horizon of 90 days Statera Biopharma is expected to under-perform the Mymetics Corp. But the pink sheet apears to be less risky and, when comparing its historical volatility, Statera Biopharma is 3.1 times less risky than Mymetics Corp. The pink sheet trades about -0.16 of its potential returns per unit of risk. The Mymetics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2.34  in Mymetics Corp on August 28, 2024 and sell it today you would lose (2.24) from holding Mymetics Corp or give up 95.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.88%
ValuesDaily Returns

Statera Biopharma  vs.  Mymetics Corp

 Performance 
       Timeline  
Statera Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Statera Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Statera Biopharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Mymetics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mymetics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Mymetics Corp is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Statera Biopharma and Mymetics Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Statera Biopharma and Mymetics Corp

The main advantage of trading using opposite Statera Biopharma and Mymetics Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Statera Biopharma position performs unexpectedly, Mymetics Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mymetics Corp will offset losses from the drop in Mymetics Corp's long position.
The idea behind Statera Biopharma and Mymetics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital